File size: 16,683 Bytes
d3f66d2 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 | ID,author,year,cancerType,cellLine,time,coumarin,coumarinDose,viability,viabilitySD,viabilityN,control,controlSD,controlN
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,16.7,93.61,6.39,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,33.4,85.81,2.13,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,66.8,78.95,8.04,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,133.6,52,11.35,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,16.7,92.67,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,33.4,79.9,5.2,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,66.8,53.19,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,133.6,37.58,5.91,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,16.7,97.87,1.42,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,33.4,91.48,6.62,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,66.8,60.04,14.19,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,133.6,44.2,5.44,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,16.7,84.86,5.21,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,33.4,69.97,4.26,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,66.8,65.01,6.43,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,133.6,43.26,3.54,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,16.7,74.94,11.34,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,33.4,72.1,10.16,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,66.8,69.97,6.43,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,133.6,41.13,5.67,3,92.9,7.1,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,31.49,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,47.93,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,3.13,88.38,6.36,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,6.25,82.32,2.38,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,12.5,71.21,5.57,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,25,55.34,6.1,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,50,41.59,3.44,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,100,22.53,0.79,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,3.13,88.35,11.65,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,6.25,85.44,7.41,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,12.5,72.25,19.84,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,25,69.04,5.03,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,50,64.28,9.26,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,100,18.78,3.45,3,100,3.36,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,5,93.33,8.23,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,10,94.5,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,20,92.15,6.66,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,40,85.88,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,80,65.88,6.27,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,5,93.72,3.92,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,10,85.88,7.84,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,20,83.13,7.05,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,40,76.86,10.19,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,80,64.31,8.23,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,5,92.94,7.84,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,10,85.49,10.19,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,20,81.56,3.13,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,40,78.43,6.27,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,80,49.41,1.96,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,5,86.66,3.92,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,10,81.17,8.62,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,20,77.64,3.13,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,40,73.72,5.88,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,80,42.35,4.31,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,5,79.6,4.7,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,10,76.47,8.23,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,20,73.72,3.13,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,40,70.58,5.09,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,80,34.9,5.88,3,77.25,6.66,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,16.7,99.25,4.32,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,33.5,100.37,2.47,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,67,99.04,3.7,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,134,97.71,3.09,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,16.7,103.91,2.47,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,33.5,96.98,3.09,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,67,84.53,3.7,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,134,76.37,4.34,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,16.7,105.6,9.87,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,33.5,102.49,10.49,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,67,87.02,4.32,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,134,75.27,8.02,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,16.7,80.24,7.95,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,33.5,78.18,6.43,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,67,62.05,4.28,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,134,45.63,6.42,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,16.7,91.8,3.67,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,33.5,82.35,1.83,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,67,60.04,9.48,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,134,47.54,6.12,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,16.7,88.86,1.83,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,33.5,78.25,6.41,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,67,56.34,7.95,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,134,40.24,1.83,3,88.2,3.67,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,167.6,70.16,2.76,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,335.2,51.93,3.31,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,167.6,57.91,3.34,3,100,2.09,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,335.2,42.5,2.91,3,100,2.09,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,2.5,90.94,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,5,86.41,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,10,75.09,7.55,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,20,55.09,16.6,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,40,28.3,2.26,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,2.5,86.41,9.43,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,5,84.9,19.62,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,10,70.18,19.63,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,20,56.6,3.77,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,40,45.66,17.35,3,100,9.05,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,12.5,92.84,13.58,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,25,80.73,9.91,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,50,48.44,6.23,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,100,42.2,4.03,3,100,2.91,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,12.5,108.62,21.65,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,25,109.35,13.21,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,50,67.88,14.68,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,100,35.59,3.67,3,100,6.6,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,12.5,66.42,15.78,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,25,44.77,10.27,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,50,29.35,1.47,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,100,29.72,1.1,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,12.5,86.97,3.3,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,25,84.4,4.4,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,50,48.44,3.67,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,100,44.03,4.41,3,100,8.07,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,1,89.04,6.18,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,2,98.87,10.68,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,5,100.28,10.67,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,10,68.25,8.99,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,15,25.28,5.33,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,20,18.82,3.93,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,25,15.73,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,30,15.16,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,40,16.57,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,50,17.97,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,1,107.26,4.93,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,2,106.84,6.17,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,5,95.75,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,10,96.98,6.99,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,15,76.84,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,20,74.79,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,25,65.34,5.75,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,30,56.71,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,40,51.78,4.52,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,50,51.36,5.35,3,100,3.36,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,10,98.62,1.83,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,20,100,4.3,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,10,97.8,1.74,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,20,95.7,4.3,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,40,79.2,10.7,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,10,81.2,15.58,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,20,87.3,3.52,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,40,76,11.61,3,98.9,2.01,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,1,90.2,2.45,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,3,88.73,4.9,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,10,78.93,3.93,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,30,52.46,2.46,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,1,87.09,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,3,84.22,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,10,57.9,2.87,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,30,19.14,1.43,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,1,99.53,3.3,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,3,100,2.8,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,10,98.12,2.82,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,30,87.74,1.89,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,144,Auraptene,30,71,0.5,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,61.3,50,3.65,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,103.8,75,4.79,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,207.7,49.24,2.52,3,100,3.36,3
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,12.25,81.44,6.09,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,25,75.34,5.54,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,50,62.04,5.81,6,100,3.36,6
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,70,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Auraptene,60,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,0.1,103.26,12.76,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,1,99.11,7.12,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,10,89.91,6.23,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,50,70.91,4.75,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,100,26.11,6.82,2,100,3.36,2
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,12.5,105.25,3.94,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,25,106.37,8.45,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,50,84.99,5.34,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,100,75.42,2.53,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,12.5,80.44,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,25,61.85,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,50,50.7,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,100,38.76,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,12.5,76.01,1.75,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,25,59.12,2.91,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,50,46.89,3.2,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,100,42.52,5.53,3,100,2.04,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,15,99.68,2.02,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,30,80.42,7.84,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,60,63.39,3.36,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,90,60.48,2.91,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,120,43.68,2.46,3,100,3.36,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,15,87.81,3.59,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,30,79.3,1.57,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,60,70.34,1.56,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,90,62.72,3.36,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,120,57.34,2.24,3,100,2.24,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,15,72.04,2.31,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,30,60.21,3.58,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,60,56.45,2.33,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,90,41.03,2.28,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,120,33.15,5.02,3,100,2.8,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,40,89.38,11.02,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,80,80.81,2.04,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,160,77.55,2.45,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,330,46.53,2.45,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,6.25,94.44,2.96,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,12.5,92.59,1.48,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,25,87.03,3.34,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,50,84.07,2.59,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,100,58.14,2.6,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,200,41.48,1.48,3,100,3.36,3 |